Antitumor Efficacy of Oncolytic Herpes Virus Type 1 Armed with GM-CSF in Murine Uveal Melanoma Xenografts
Sisi Liu,1 Fusheng Liu,2 Mingwei Zhao,1 Junwen Zhang2 1Department of Ophthalmology, Peking University People’s Hospital, Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Sci...
Main Authors: | Liu S, Liu F, Zhao M, Zhang J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-11-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/antitumor-efficacy-of-oncolytic-herpes-virus-type-1-armed-with-gm-csf--peer-reviewed-article-CMAR |
Similar Items
-
Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer
by: Coby Rangsitratkul, et al.
Published: (2022-03-01) -
Optimising Hydrogel Release Profiles for Viro-Immunotherapy Using Oncolytic Adenovirus Expressing IL-12 and GM-CSF with Immature Dendritic Cells
by: Adrianne L. Jenner, et al.
Published: (2020-04-01) -
Modelling combined virotherapy and immunotherapy: strengthening the antitumour immune response mediated by IL-12 and GM-CSF expression
by: Adrianne L. Jenner, et al.
Published: (2018-06-01) -
Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)
by: Robert J. Soiffer, et al.
Published: (2021-06-01) -
GM-CSF: A Promising Target in Inflammation and Autoimmunity
by: Lee KMC, et al.
Published: (2020-10-01)